Knowing which countries to submit clinical trial results summaries to is the easy part. What becomes difficult is learning the intricacies and transparency requirements of every clinical trial registry globally, including the German Clinical Trials Register (DRKS). Here is an overview of this registry:

Registry name: German Clinical Trials Register (DRKS)

Country: Germany

Year established: 2008

Points of interest:

  • The DRKS was funded by the Federal Ministry of Education and Research (BMBF) and implemented at the Center for Medical Biometry and Medical Informatics at the University Medical Center Freiburg.
  • Since 2017, the DRKS was maintained by the German Institute of Medical Documentation and Information (DIMDI)
  • Since October 2008, the DRKS has been approved as a WHO Primary Register and complies with the International Committee of Medical Journal Editors (ICMJE) requirements
  • The goal of the DRKS, as stated on their website, is to provide a central portal for information on clinical research in Germany
  • The DRKS cooperates with the German Society of Urology and the German Cancer Society
  • Information on the register is available in both German and English
  • The DRKS is the only study registry in Germany recognized by the WHO
  • While Germany does not legally require clinical trials to be registered, all trials that include patients in Germany should be registered in DRKS

Related transparency research/articles:

TrialAssure® Registry can automate the disclosure of clinical trial results for DRKS. For questions or a free demo, fill out this form.